CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 41 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q3 2021. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58,896,759 | +1.0% | 9,103,054 | -3.4% | 1.59% | -2.3% |
| Q2 2023 | $58,329,701 | +60.8% | 9,423,215 | 0.0% | 1.63% | +22.6% |
| Q1 2023 | $36,279,378 | +69.7% | 9,423,215 | +36.7% | 1.33% | +47.0% |
| Q4 2022 | $21,372,470 | -22.9% | 6,894,345 | 0.0% | 0.90% | -21.2% |
| Q3 2022 | $27,715,000 | -17.5% | 6,894,345 | 0.0% | 1.14% | -29.4% |
| Q2 2022 | $33,575,000 | +113.2% | 6,894,345 | +292.7% | 1.62% | +157.3% |
| Q1 2022 | $15,747,000 | +207.7% | 1,755,545 | +286.2% | 0.63% | +238.7% |
| Q4 2021 | $5,118,000 | +291.3% | 454,545 | +671.7% | 0.19% | +279.6% |
| Q2 2021 | $1,308,000 | – | 58,900 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Index Venture Life Associates VI Ltd | 9,961,789 | $112,170,000 | 100.00% |
| Medicxi Ventures Management (Jersey) Ltd | 18,123,892 | $204,075,000 | 51.07% |
| Vida Ventures Advisors, LLC | 3,931,818 | $44,272,000 | 16.56% |
| OUP Management Co., LLC | 2,341,891 | $26,370,000 | 11.89% |
| Samsara BioCapital, LLC | 1,459,693 | $16,436,000 | 3.19% |
| VR Adviser, LLC | 1,127,272 | $12,693,000 | 1.74% |
| Affinity Asset Advisors, LLC | 419,144 | $4,720,000 | 1.71% |
| Cormorant Asset Management, LP | 2,489,894 | $28,036,000 | 1.67% |
| Kynam Capital Management, LP | 239,041 | $2,692,000 | 1.44% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $109,017,000 | 0.84% |